Aisling CapitalInvestor Details

Get alertedif Aisling Capital makes an investment
Aisling Capital
Country:
State:
City:
United States
New York
New York City
Industry:Finance
Company description

Aisling Capital is a late-stage life sciences investment partnership that leverages nearly 20 years of capital markets and clinical experience to invest in the development of breakthrough therapeutics that improve and save lives.

 

Funding history

DateDeal sizeInvestors
November 2nd, 2017$280,000,000-
Want to know when Aisling Capital invests in a new company?
Portfolio:
Ajax Health (2019: $15,000,000 raised)
Poseida Therapeutics Inc (2019: $142,000,000 raised)
Bridgebio Llc (2019: $299,200,000 raised)
Earlens Corporation Inc (2018: $87,000,000 raised)
Nference (2018: $11,000,000 raised)
Eidos Therapeutics (2018: $64,000,000 raised)
Arcus Biosciences (2017: $107,000,000 raised)
Menlo Therapeutics (2017: $50,000,000 raised)
Earlens Corporation Inc (2017: $45,000,000 raised)
Promentis Pharmaceuticals Inc (2017: $26,000,000 raised)
Biohaven Pharmaceutical Holding Company Ltd (2016: $80,000,000 raised)
Verona Pharma Plc (2016: $65,600,000 raised)
F2g Ltd (2016: $60,000,000 raised)
Zavante Therapeutics Inc (2016: $35,000,000 raised)
Spirox Inc (2016: $45,000,000 raised)
Syros Pharmaceuticals (2016: $40,000,000 raised)
Allergen Research Corp (2015: $80,000,000 raised)
Syros Pharmaceuticals (2014: $53,000,000 raised)
Dermira Inc (2014: $51,000,000 raised)
Cidara Therapeutics (2014: $32,000,000 raised)
Powervision Inc (2014: $30,000,000 raised)
Loxo Oncology Inc (2014: $24,000,000 raised)
Viewray Inc (2014: $30,000,000 raised)
Versartis Inc (2013: $20,000,000 raised)
Loxo Oncology Inc (2013: $33,000,000 raised)
Lensar Inc (2013: $87,000,000 raised)
Esperion Therapeutics (2013: $33,000,000 raised)
T2 Biosystems Inc (2013: $40,000,000 raised)
Versartis Inc (2013: $25,000,000 raised)
Ambit Biosciences Corp (2012: $25,000,000 raised)
Axiomed Spine (2012: $5,000,000 raised)
Cytos Biotechnology Ag (2012: $32,600,000 raised)
Lensar Inc (2012: $24,000,000 raised)
Aragon Pharmaceuticals Inc (2012: $42,000,000 raised)
Coinvestors:
New Enterprise Associates
OrbiMed Advisors
Longitude Capital
Polaris Partners
Ra Capital Management
Rock Springs Capital
Advent Life Sciences Fund
Aperture Venture Partners Llc
Cochlear
Fidelity Biosciences
Flagship Ventures
Foresite Capital
Healthquest Capital
Index Ventures
Kearny Venture Partners
Kkr
Lightstone Ventures Lp
New Leaf Venture Partners Llc
Novo A/S
Orbimed
Redmile Group
The Column Group
Venrock
Vivo Capital
5AM Ventures
ARCH Venture Partners
Abingworth
Adage Capital
Advent Life Sciences Llp
Alexandria Venture Investments
Alta Partners
Amunix Operating Inc
Amzak Health Investors
Apple Tree Partners
Apposite Healthcare
Arboretum Ventures And Asset Management
Arch Healthcare
Arcus Ventures
Arix Bioscience
Baltisches Haus Ltd
Bay City Capital Llc
Black Pearl Gmbh
Boxer Capital Llc
Brace Pharma Capital
Bridgebio Pharma
Bvf Partners
Camros Capital
Canaan Partners
Casdin Capital
Celgene
Connecticut Innovations
Cormorant Asset Management
Cormorant Capital
Correlation Venture Partners
Cowealth Medical Holding Co Ltd
Crg
Crg Partners
Decheng Capital
Deerfield Management Company
Domain Associates
Droia
Ecor1 Capital
Edmond de Rothschild Investment Partners
Exor Seeds
F-prime Capital Partners
Far East Ventures
Fidelity Management & Research Company
Florida Growth
Florida Growth Fund
Florida Opportunity Funds
Flybridge Capital Partners Lp
Forward Ventures
Frazier Healthcare
Frazier Healthcare Partners
Gdn Holdings
Gimv
Golden Angel Network
Goldman Sachs
Growthworks
Gv (google Ventures)
Hargreave Hale
Hercules Capital
Hillhouse
InterWest Partners
Invus Opportunities
Ivo Capital
Kck Medical Technologies Group
Knoll Capital Management
Leerink Partners Llc
Litmore Capital
Malin Corp
Matrix Capital Management
Matrix Partners
Medimmune Ventures Inc
Medtronic Corp
Merifin Capital
Ms Pace Lp
New Enterprise Associates (nea)
Novartis
Novartis Venture Fund
Novo Holdings A/s
Osage University Partners
Paig
Palo Alto Investors
Partners Healthcare
Pdl Biopharma
Pentwater Capital Management Lp
Physic Ventures
Polar Capital
Radius Ventures
Rapha Capital Management
Relativity Health Fund
Rk Mellon
Roche Ventures
Sabby Capital
Sectoral Asset Management
Sequoia Capital
Siemens Venture Capital
Sightline Healthcare Opportunity
Sightline Partners
Sofinnova Ventures
Sunstone Capital
Taiho Ventures
Topspin Fund
Ucb
Venbio
Vertex Global Healthcare
Vertex Healthcare
Viking Global Investors
Viking Venture
Wellington Management
Windham Life Sciences Partners
Windham Venture Partners
Ws Investments
Wuxi Pharmatech Corporate Venture Fund
Wuxi Ventures Funds
This list displays investors that took part in the same funding round as Aisling Capital since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!